“…Novel transcatheter therapeutics for congenital heart disease have emerged, with significant advancement over the past few decades. [7][8][9] Although the cost of transcatheter pulmonary valve implantation is a major factor for its limited use in dogs, 10 rare cases of nonvalved stent implantation have been reported as palliative therapy for dogs with PS. [11][12][13] This report describes the process of transpulmonary stent implantation in a dog with severe PS and a coronary anomaly.…”